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Abstract: Synthetic amphiphilic polymers have been established as potentially efficient
agents to combat widespread deadly infections involving antibiotic resistant superbugs.
Incorporation of poly(ethylene glycol) (PEG) side chains into amphiphilic copolymers can
reduce their hemolytic activity while maintaining high antibacterial activity. Our study found
that the incorporation of PEG has substantially different effects on the hemolytic and
antibacterial activities of copolymers depending on structural variations in the positions of
cationic centers relative to hydrophobic groups. The PEG side chains dramatically reduced
the hemolytic activities in copolymers with hydrophobic hexyl and cationic groups on the
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same repeating unit. However, in case of terpolymers with cationic and lipophilic groups
placed on separate repeating units, the presence of PEG has significantly lower effect on
hemolytic activities of these copolymers. PEGylated terpolymers displayed substantially
lower activity against Staphylococcus aureus (S. aureus) than Escherichia coli (E. coli)
suggesting the deterring effect of S. aureus’ peptidoglycan cell wall against the penetration
of PEGylated polymers. Time-kill studies confirmed the bactericidal activity of these
copolymers and a 5 log reduction in E. coli colony forming units was observed within 2 h of
polymer treatment.
Keywords: antimicrobial polymers; amphiphilic polymers; polyacrylates; drug-resistant
bacteria; PEGylated; bactericidal agents

1. Introduction
The global health threat from infections involving antibiotic resistant bacteria (superbugs) have created
a pressing need to develop new antibacterial agents [1,2]. Antimicrobial resistance to antibiotics causes
thousands of deaths and adds billions of dollars to health care budget in the Unites States alone [3–5].
It has been recently estimated that antimicrobial resistance will result in 10 million annual deaths by
2050 [6]. The problem of antibiotic resistance is further compounded by sharp decline in number of new
antibiotics introduced in market in recent years due to high costs involved in their development facing
the rapid development of microbial resistance against antibiotics [1]. Synthetic cationic amphiphilic
polymers mimicking the principle features of natural antimicrobial peptides (AMPs) have emerged as
promising candidates to fight against superbugs [7,8]. AMPs and their synthetic mimics are known to
disrupt the negatively charged bacterial cell surface through electrostatic and lipophilic interactions [9–11].
This mechanism of bacterial cell surface rupture through non-specific interactions leads to highly
hindered or improbable development of bacterial resistance, which is in contrast to the rapid resistance
development against conventional antibiotics with target specific mode of action [9]. The lack of bacterial
resistance development towards synthetic amphiphilic polymers have been reported [12], whereas the
development of significant bacterial resistance against conventional antibiotic is well documented.
For widespread therapeutic applications, synthetic polymers with high antibacterial activity and
concomitant low hemolytic activity and toxicity towards mammalian cells are desired. Research efforts
have been focussed to ascertain the effects of various macromolecular structural parameters on the
hemolytic and antibacterial activities of synthetic amphiphilic polymers. Structural parameters that have
been reported to significantly impact the hemolytic and antibacterial activities include the block versus
random copolymer architecture [13], amphiphilic balance [14], type of cationic charge [15], facially
versus segregated amphiphilicity [16], charge density [17], backbone spacer distance [18], and terminal
groups [19]. We have reported that the control of spatial charge distribution in polyacrylates with various
compositions of 6-carbon and 2-carbon spacer arm (distance between polymer backbone to cationic
center) repeat units can lead to polymers with high antibacterial and concomitant low hemolytic activity [20].
In another approach, we investigated the hemolytic and antibacterial activities of polyacrylates (6-carbon
spacer arm counits) as a function of polymer amphiphilicity through control of non-ionic hydrophilic
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poly(ethylene glycol) (PEG) content [21]. The cationic homopolymer with 6-carbon spacer arms
PM6-100%, i.e., poly(6-aminohexylacrylate), is highly hemolytic and antibacterial [20,22]. We found
that the incorporation of just 33 mol % of poly(ethylene glycol) methyl ether methacrylate comonomer
(PEGMA-300) units in this 6-carbon spacer arm polymer led to >1300 times reduction in hemolytic
activity while maintaining high antibacterial activity, leading to >100 times selectivity against
Escherichia coli (E. coli) over red blood cells (RBCs) [21]. In these copolymers with long hexyl spacer
arms, the cationic charge and hydrophilic moieties are present on the same repeating unit. It would be
of importance to understand the effect of polymer structure, in terms of relative placement of cationic
and hydrophobic groups, on the impact of PEGylation on hemolytic and antibacterial activities of
amphiphilic polymers.
The aim of present investigation is to explore the effect of PEG group incorporation in copolymers
having cationic groups and hydrophobic alkyl chains on separate repeating units. These results can be
directly compared with our recently synthesized PEGylated 6-carbon spacer arm polymers with cationic
and alkyl groups on the same repeating units [21]. Our study revealed that the incorporation of PEG
counits has substantially different effects on the antibacterial and hemolytic activities of polymers
with topographical differences in the placement of cationic groups relative to hydrophobic groups.
The copolymers displayed high bactericidal activity with 5 log reduction of E. coli colony forming units
within 2 h of treatment with a copolymer.
2. Results and Discussion
2.1. Synthesis of Copolymers
The copolymers were synthesized through free radical copolymerization of 2-((tert-butoxycarbonyl)
amino)ethyl acrylate and PEGMA-300 with butyl or hexyl acrylate using 2,2'-azobis(2methylpropionitrile) (AIBN) as a free radical initiator and methyl 3-mercaptopropionate (MMP) as a
chain transfer agent (Figure 1) [20,21]. Two series of copolymers, one with butyl side groups and the
other with hexyl side groups were synthesized to explore the effect of copolymer hydrophobicity on the
antibacterial and hemolytic activities. The ratio of monomers to AIBN and MMP was kept constant to
obtain similar molecular weights for all copolymers. Molecular weights of copolymers were estimated
against linear polystyrene standards using gel permeation chromatography and found to be similar for
all copolymers (Mn ~ 4000 g/mol). The feed mole ratio of 2-((tert-butoxycarbonyl)amino)ethyl acrylate
to hexyl or butyl acrylate was kept constant at 60:40, whereas the feed mole ratio of PEGMA-300 (PEG
side groups degree of polymerization (DP)~5) was varied from 0 mol % to 50 mol % in increments of
10 mol %. Copolymers with 75 mol % of PEGMA were also synthesized. The DP of PEG side group
was kept at 5 ethylene glycol units as our earlier study has found that PEGMA-300 led to polymers with
higher selectivities against bacteria over RBCs, as compared with copolymers incorporating longer
PEG side groups (DP~19, PEGMA-950) [21]. The actual feed ratios of polymers were confirmed
using 1H-NMR spectroscopy and found to be in close agreement with the feed mole ratios (supporting
information). For the removal of N-Boc protecting groups, copolymers were treated with excess
trifluoroacetic acid. The nomenclature of PB-PEG X% is used to identify the cationic copolymer
with butyl acrylate comonomer units and X mol % (in feed) of PEGMA-300 comonomer units.
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Similarly, PH-PEGX % represents the copolymer with hexyl acrylate and X mol % (in feed) of
PEGMA-300 counits.

Figure 1. (A) Effect of relative topographical positions of cationic and lipophilic groups on
the biological activities of PEGylated copolymers (The questions marks in part A signifies
that the antibacterial and hemolytic activities of the terpolymer is unknown and the aim of
this study was to explore the activities of this terpolymer); and (B) Synthesis of cationic
amphiphilic copolymers through free radical polymerization.
2.2. Antibacterial Activity of Copolymers
The antibacterial activities of copolymers were determined against both gram negative E. coli
(ampicillin resistant) and the gram positive Staphylococcus aureus (S. aureus) bacteria in terms of
minimum inhibitory concentrations (MIC). MIC is defined as the lowest polymer concentration required
to completely inhibit bacterial growth after an incubation period of 18 h. As apparent from Figure 2
and Table 1, PH-PEG-0% displayed high antibacterial activity towards both E. coli and S. aureus.
Kuroda et al. have reported high antibacterial activity in polymethacrylate copolymers having high mol
% of hydrophobic butyl side groups [23]. As compared with PH-PEG-0%, PH-PEG-10% showed higher
activity against E. coli (MIC: 16 µg/mL). Addition of small mol % of non-ionic hydrophilic PEG content
has been previously reported to enhance the antibacterial activity of N-hexylated poly(vinyl pyridines)
due to increased wettability in aqueous medium and hence better interactions with the bacterial cell
surface [24]. In PH-PEG-0%, high hydrophobicity due to long hexyl side groups can lead to hydrophobic
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associations of polymer chains in aqueous solution leading to lower number of polymer chains available
for interactions with the bacterial cells [23]. Further increase in the mol % of PEGMA-300 repeat units
till 50 mol % did not substantially deteriorate the antibacterial activity of these copolymers, but higher
than 50 mol % (75 mol %) content led to complete loss of activity against E. coli (MIC > 1000 µg/mL).
Similar to the effect of PEG on PH copolymer series with hexyl side groups, the addition of PEG side
groups did not drastically reduce the antibacterial activities of PB series copolymer until 50 mol % of
PEGMA-300 content, and copolymer with 75 mol % was not active against E. coli. These observations
are similar to the effects of PEG content on the antibacterial activities of PEGylated PM6 copolymers
(Table 1) with cationic charge and hydrophobic hexyl spacer arms on the same repeat units [21].

Figure 2. Antibacterial (MIC) and hemolytic activities (HC50) of (A) PB-PEG-X% series,
terpolymers of butyl acrylate (shown in red in structure), 2-((tert-butoxycarbonyl)amino)ethyl
acrylate, and PEGMA-300; (B) PH-PEG-X% series, terpolymers of hexyl acrylate (shown in
red in structure), 2-((tert-butoxycarbonyl)amino)ethyl acrylate, and PEGMA-300. Error bars
represent standard deviation.
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Table 1. Characterization and biological activities of amphiphilic polyacrylates.

Copolymer

Alkyl Side Group

Mol % PEGMA-300
(Actual)

Mn [g/mol]
kDa

MIC E. coli
[µg/mL]

MIC S. aureus
[µg/mL]

HC50 RBC
[µg/mL]

PB-PEG-0%
PB-PEG-10%
PB-PEG-20%
PB-PEG-30%
PB-PEG-40%
PB-PEG-50%
PB-PEG-75%
PH-PEG-0%
PH-PEG-10%
PH-PEG-20%
PH-PEG-30%
PH-PEG-40%
PH-PEG-50%
PH-PEG-75%
PM6-100 *
PM6-90-PEG300 *
PM6-70-PEG300 *
PM6-50-PEG300 *
PM6-30-PEG300 *

Butyl
Butyl
Butyl
Butyl
Butyl
Butyl
Butyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl
Hexyl

0%
17%
23%
33%
44%
53%
72%
0%
11%
21%
27%
35%
46%
72%
0%
10%
33%
50%
71%

4.0
4.2
3.8
4.1
4.2
4.5
4.6
3.4
3.6
3.8
3.9
4.6
4.6
6.4
5.8
5.1
5.2
5.1
5.9

16
52
42
31
62
167
2000
62
16
21
21
42
83
1190
6.5
7.8
16
104
>1809

62
83
125
250
604
1143
2000
42
62
83
384
384
1143
2000
16
31
62
250
>2000

<12
<12
24
140
317
1000
2000
<12
<12
24
24
62
125
1500
<1.9
83
>1809
>2000
>200

* Yang et al. [21].

Selectivity HC50/MIC
E. coli

S. aureus

<1
<1
<1
4.5
5
6
1
<1
<1
1
1
1.5
1.5
1.3
<1
11
>113
>19
>1

<1
<1
<1
<1
<1
<1
1
<1
<1
<1
<1
<1
<1
<1
<1
2.6
>29
>8
1

Int. J. Mol. Sci. 2015, 16

23873

As shown in Figure 2 and Table 1, these PEGylated terpolymers displayed substantially lower activity
against gram positive S. aureus, as compared with gram negative E. coli. Furthermore, increasing the
PEGMA-300 content from 0 mol % to 40 mol % led to dramatic reduction in activity against S. aureus.
Similarly, PEGylated PM6 copolymers (Table 1) previously demonstrated lower activity against
S. aureus than E. coli [21]. These observations are in contrary to other studies that reported higher
activities of synthetic amphiphilic polymers (without PEG) against S. aureus than E. coli [25–27].
The double membrane structure of E. coli cell surface can be considered more difficult to penetrate
than the single membrane cell surface of S. aureus [25]. However, dramatically lower activity of these
PEGylated copolymers against S. aureus than E. coli suggests the probable hydrogen bonding
associations of long PEG side groups with the thick (15–80 nm) peptidoglycan cell wall of S. aureus,
thus hindering the permeabilization of PEGylated polymers through the cell surface of S. aureus.
2.3. Hemolytic Activity of Copolymers
The toxicity of these copolymers against mammalian cells was ascertained in terms of hemolytic
activity against freshly drawn mice RBCs. Hemolytic concentration-50% (HC50) is defined as the lowest
polymer concentration required to lyse 50% of RBCs within an incubation period of 1 h. The hemolytic
activity of amphiphilic polymers has been mainly attributed to the permeabilization of polymers into
the hydrophobic core of RBC’s lipid bilayer through lipophilic interactions [28]. The outer leaflet
of RBCs’ cell membrane lacks net negative charge in contrary to the negatively charged cell surface of
bacteria [28]. The incorporation of hydrophilic PEG side groups is expected to reduce the hemolytic
activities of synthetic amphiphilic polymers. Similar to the protective action of blood plasma, PEG is
believed to hinder the damage to RBCs from the foreign body contact [29]. PEG can weakly adsorb on
the surface of RBCs thus further enhancing its protective action [30]. Moreover, the addition of
hydrophilic PEG groups can reduce the overall hydrophobicity of polymers and then their insertion
through the hydrophobic core of RBC’s lipid bilayer.
However, majority of these PEGylated terpolymers displayed high hemolytic activity (Figure 2 and
Table 1). As shown in Table 1, both PM6-100% (HC50 < 2 µg/mL) and PB-PEG-0% (HC50 < 12 µg/mL)
displayed high hemolytic activities. However, incorporation of just 33 mol % of PEGMA-300 led to
dramatic reduction in hemolytic activity (HC50 > 1809 µg/mL) in PM6-70-PEG300 leading to >113
times selectivity (HC50/MIC) against E. coli over RBCs. In comparison, PB copolymers showed
substantially higher hemolytic activity till 50 mol % of PEG side groups. Thus, the topographical
placement of cationic centers relative to hydrophobic alkyl moieties significantly affects the ability of
PEG groups to reduce the hemolytic activity of these amphiphilic copolymers. In PM6-70-PEG300, with
hexyl groups (as spacer arms) present on the same repeating unit with cationic groups, the addition of
PEG dramatically reduced the hemolytic activities of this copolymer. On the other hand, PB-PEG-40%
containing butyl and cationic groups (attached to 2-carbon spacer arm) on separate repeat units displayed
high hemolytic activity despite the high PEG mol % content. Tew and co-workers have previously
reported that “facially amphiphilic” polynorbornenes demonstrated higher selectivities against bacteria
over RBCs, as compared with “segregated” polynorbornenes with cationic and alkyl groups on separate
repeat units [16]. Similarly, Sen and co-workers have shown higher selectivity of poly(vinyl pyridines)
against bacteria over RBCs as compared with separate center copolymers [31]. Our investigations have
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revealed that the relative positions of cationic and hydrophobic groups along the polymer backbone can
have dramatic effect on the ability of PEG groups to protect erythrocytes from the lytic ability of
synthetic amphiphilic polyacrylates and these results can have implications in the design of PEGylated
polymers for biomedical applications.
PH series copolymers in general displayed higher hemolytic activity than the PB series with shorter
butyl side groups. This result is expected due to higher hydrophobicity of copolymers with longer hexyl
side groups leading to higher ability of these copolymers to rupture the cell membrane of RBCs through
lipophilic interactions.
2.4. Time Dependent Killing Efficiency of Copolymers
Time dependent killing efficiencies of PB-PEG-30% and PH-PEG-30% were obtained against E. coli
and S. aureus (Figure 3). Both polymers displayed high bactericidal efficiency against E. coli and a 5 log
reduction in E. coli colony forming units was obtained within 2 h of incubation with 1 × MIC
concentration of PH-PEG-30%. These results confirmed the killing activity of these polymers, as
opposed to only bacteriostatic activity and indicate that the minimum bactericidal concentration of these
polymers against E. coli is equal to their minimum inhibitory concentrations.

Figure 3. E. coli colony forming units (CFUs) after treatment with PB-PEG-30% at (A) 0 h
and (B) at 6 h time interval. Time dependent killing efficiency of PB-PEG-30% and
PH-PEG-30% copolymers at 1 × MIC concentration against (C) E. coli and (D) S. aureus.
PB-PEG-30% and PH-PEG-30% terpolymers incorporate approximately 30 mol % of
PEGMA-300. Error bars represent standard deviation.
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As discussed above, these PEGylated copolymers demonstrated significantly lower activity against
S. aureus than E. coli. As apparent from Figure 3, a substantial number of S. aureus colonies survived
after treatment with 1 × MIC concentration of PB-PEG-30% even after 6 h of treatment, whereas more
than 98% E. coli were killed within 2 h of treatment with PB-PEG-30%. In contrast to PB-PEG-30%,
PH-PEG-30% displayed 100% killing against S. aureus at 1 × MIC concentration. Longer hexyl groups
in PH-PEG-30% can lead to higher cell membrane permeability of polymer chains due to increased
hydrophobic interactions with bacterial cell surface. Longer hydrophobic hexyl side groups can lead to
more collapsed conformation of polymer chains in the aqueous medium leading to reduced association
of PEG groups with the S. aureus cell wall.
3. Experimental Section
3.1. Materials
Ethanolamine, hexyl acrylate, butyl acrylate, 2,2ʹ-azobis(2-methylpropionitrile) (AIBN), methyl
3-mercaptopropionate (MMP), acetonitrile (anhydrous), N,N-diisopropylethylamine, and tetrahydrofuran
(THF) were purchased from Sigma-Aldrich (Milwaukee, WI, USA) and used without further
purification. Poly(ethylene glycol) methyl ether methacrylate (PEGMA-300, Mn ~300 g/mol) and
acryloyl chloride were purchased from Sigma-Aldrich. Acryloyl chloride was distilled prior to use and
poly(ethylene glycol) methyl ether methacrylate was purified (inhibitor removal) by silica gel column
chromatography using dichloromethane as eluent. Trifluoroacetic acid (TFA), di-tert-butyl dicarbonate
(t-Boc), hexane, and diethyl ether were purchased from Alfa Aesar (Ward Hill, MA, USA).
Dichloromethane and ethyl acetate were purchased from BDH/VWR (Bridgeport, CT, USA). All other
chemicals or reagents were used as obtained without further purification.
3.2. Instrumentation
1

H-NMR spectra of polymers were obtained on a Varian NMR spectrometer (600 MHz, Varian: Palo
Alto, CA, USA) using D2O as solvent. The molecular weights (MW, Mn, and polydispersities) of
precursor polymers (N-Boc protected) were estimated on an EcoSec HLC-83220 gel permeation
chromatography instrument (RI detector, TSKgel SuperHZ-N (3 µm 4.6 mm ID) and TSKgel Super
HZ-M (3 µm 4.6 mm ID) columns) by Tosoh Bioscience (Tosoh Bioscience LLC: South San Francisco,
CA, USA). Linear polystyrenes were used as standards and THF was used as an eluent at a flow rate of
0.35 mL/min. An Agilent 8453 spectrophotometer (Agilent Technologies, Inc.: Santa Clara, CA, USA)
was used to measure bacterial cell growth (using 1 cm path length plastic cuvette) in E. coli and S. aureus
cell cultures. SpectraMax 340 PC microplate reader from Molecular Devices (Molecular Devices:
Sunnyvale, CA, USA) was used to obtain OD595 (optical density at wavelength of 595 nm) for
antibacterial test and OD414 for hemolysis test.
3.3. N-Boc Protection of Ethanolamine
Eight milliliters (132 mmol) of ethanolamine was added into a 250 mL round bottom flask containing
132 mL deionized water. Thirty milliliters (130 mmol) of di-tert-butyl dicarbonate (t-Boc) was then
dropwise added [20]. The reaction mixture was left under stirring at room temperature for 3 h.
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N-Boc protected ethanolamine was extracted using ethylacetate (3 × 125 mL) and the organic phase was
separated and dried with sodium sulfate. Excess solvent was removed using a rotary evaporator under
reduced pressure. The final product was obtained as white powder in 92% yield. 1H-NMR (600 MHz,
CDCl3): δ 1.4 (s, 9H), 3.3 (m, 2H), 3.7 (m, 2H), 5.3 (s, 1H).
3.4. Synthesis of 2-((Tert-butoxycarbonyl)amino)ethyl Acrylate Monomer
Fourteen grams (87 mmol) of N-Boc ethanolamine was added in a 500 mL two neck round bottom
flask already charged with 23 mL (130 mmol) N,N-diisopropylethylamine and 130 mL anhydrous
dichloromethane [20]. The reaction mixture was closed and purged with nitrogen. A volume of 7.32 mL
of acryloyl chloride was added dropwise into the reaction mixture (while stirring) under nitrogen
atmosphere at 0 °C. The reaction mixture was allowed to warm to room temperature and left under
stirring for 18 h. The reaction mixture was then washed with deionized water (3 × 125 mL), 10% citric
acid (3 × 125 mL), 10% potassium carbonate solution (3 × 125 mL), and saturated sodium bicarbonate
solution (3 × 125 mL). The organic phase was separated and dried with sodium sulfate. Excess solvent
was removed under reduced pressure using the rotary evaporator. The resultant liquid was purified by
column chromatography using ethyl acetate/hexane (1:1) mixture as eluent. 65% yield. 1H-NMR
(600 MHz, CDCl3): 1.40 (s, 9H), 3.47 (s, 2H), 4.22 (s, 2H), 5.83 (d, 1H), 6.10 (q, 1H), 6.39 (d, 1H).
3.5. Synthesis of Copolymers
A representative synthetic procedure is as follows [20,21]. 2-((tert-butoxycarbonyl)amino)ethyl
acrylate (0.387 g, 1.8 mmol), 0.187 g (1.2 mmol) hexyl acrylate, and 0.900 g (3 mmol) PEGMA-300
were added into a 100 mL three-neck round bottom flask which was already charged with 9.85 mg
(0.06 mmol) AIBN, 33.3 µL MMP, and 6 mL anhydrous acetonitrile. The flask was sealed and degassed
with nitrogen (using stainless steel needle) for 20 min. The reaction mixture was then stirred for 18 h at
65 °C. Afterwards, acetonitrile in the solution was removed under reduced pressure using the rotary
evaporator (Buchi Analytical Inc.: New Castle, PA, USA). The polymer was dissolved in THF and
precipitated in hexane three times. In order to remove N-Boc protecting groups, the polymer was
dissolved in excess TFA and the solution was stirred at room temperature for 3 h. Afterwards the TFA
was removed under reduced pressure using the rotary evaporator and the polymer was dissolved in
methanol and precipitated in diethyl ether multiple times. Resultant polymer was kept under vacuum for
3 days and lyophilized. Yield 0.82 g.
3.6. Antibacterial Activity Test
Antibacterial activities of cationic amphiphilic copolymers were determined against E. coli (TOP 10,
ampicillin resistant) and S. aureus ATCC 25923 using a microdilution assay as described in the
literature [23]. Stock solutions (20 mg/mL) of polymers were prepared by dissolving each polymer in
dimethyl sulfoxide. To obtain different concentrations, serial dilutions and some intermediate dilutions
were prepared by further adding deionized water. Control solutions (without polymer) were similarly
prepared. E. coli bacteria were incubated overnight at 37 °C, under shaking, in culture tubes containing
Luria Bertani (LB) broth and ampicillin. Bacterial growth was measured with an Agilent 8453
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spectrophotometer (Agilent Technologies, Inc.: Santa Clara, CA, USA) using a disposable plastic
cuvette with a path length of 1 cm. The device measures turbidity at λ = 595 nm (optical density, OD595).
The bacterial culture was diluted with fresh LB to achieve the OD600 = 0.1 of cell suspension and this
suspension was incubated at 37 °C for approximately 90 min. The OD595 value was increased to 0.5,
indicating the log-phase of exponential growth. The culture was then diluted with fresh LB broth to
obtain a final OD595 value of 0.001. Polymers or control solutions were added to the 96 well cell culture
plates followed by the addition of final E. coli cell suspension and the plates were incubated at 37 °C for
18 h to promote bacterial growth. Bacterial growth was measured on a SpectraMax 340 PC microplate
reader, using turbidity at λ = 595 nm (OD595). Antibacterial activity of polymers was similarly determined
against S. aureus, except Mueller-Hinton (MH) broth was used in place of LB broth and longer log phase
time intervals were required. Minimum inhibitory concentration (MIC) is defined as the lowest polymer
concentration required to completely inhibit the bacterial growth after an incubation period of 18 h. MIC
values reported here are the averages of three independent experiments on separate days.
3.7. Hemolytic Activity Test
Hemolytic activity of copolymers was tested against mice red blood cells (RBCs) [23]. The RBCs
were obtained from centrifuging the freshly drawn blood at 3000 rpm for 15 min. Plasma and white
blood cells were removed as supernatant. RBCs were washed with TBS (Tris-buffered saline; 10 mM
Tris, 150 mM NaCl, at pH = 7) solution. The RBCs were 40-fold diluted with TBS solution to prepare
a final 0.25% RBC stock solution. The stock solution (120 µL), polymer solution (15 µL) or control
solution, and TBS solution (15 µL) were added to 600 µL micro centrifuge tubes and incubated at 37 °C
for 1 h. The tubes were then centrifuged for 5 min at 4000 rpm. The resultant supernatant (30 µL,
in triplicate) and 70 µL TBS were added in each well of the 96 well tissue culture plates. Hemoglobin
concentration was measured as OD414, and the percent hemolysis corresponding to each polymer
concentration was calculated using the following formula:
%

=

−
−

× 100

(1)

Hemolytic activity-50% (HC50) is defined as the lowest polymer concentration required to cause 50%
lyses in RBCs within an incubation period of 1 h. The HC50 values reported here are the averages of
two independent experiments performed on separate days.
3.8. Time Dependent Killing Efficiency Test
The time dependent killing efficiencies of polymers were obtained as per reported procedure [21]. E. coli
and S. aureus bacterial cell cultures were obtained in log phase growth as described above in the
antibacterial test section. A final stock solution with OD595 = 0.001 (~105 CFU/mL) was obtained by
diluting the log phase cell suspension with fresh nutrient broth (LB broth for E. coli and MH broth for
S. aureus). This final stock cell suspension was treated with polymer solutions (1 × MIC final concentration)
or deionized water (without polymer) as control. At regular time intervals (1, 2, 4, and 6 h) the bacterial
cell suspension samples were taken out. After serial dilutions (in 10 folds), 20 µL of the final dilution was
streaked on agar plates and left for incubation for 24 h at 37 °C. The colony forming units were counted
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using the image J image processing and analysis software (National Institute of Health: Bethesda, MD,
USA). Results shown here are the averages of 2 independent experiments performed on separate days.
4. Conclusions
In conclusion, PEGylated cationic amphiphilic acrylate copolymers with high antibacterial activity
against E. coli and S. aureus were synthesized. Time-kill studies revealed a 5 log reduction in E. coli
CFUs/mL within 2 h of polymer treatment. As compared with PB-PEG-30%, PH-PEG-30% with two
carbon longer alkyl side group displayed higher bactericidal activity against S. aureus with 100% killing
of S. aureus cells within 2 h. The PEGylated copolymers reported here demonstrated substantially lower
activity against S. aureus than E. coli. The hydrogen bonding association of hydrophilic PEG groups
with peptidoglycans in the thick cell wall of S. aureus can be a contributing factor to this observation.
The effect of non-ionic hydrophilic modifications on the antibacterial and hemolytic activities of
amphiphilic polyacrylates was investigated. A significantly different impact of PEGylation on the
hemolytic activities of polymers with variation in relative positions of cationic and hydrophobic centers
was observed. As reported earlier, in copolymers with cationic centers and hydrophobic units (hexyl
spacer arms) on the same repeat units, the incorporation of PEGMA-300 counits dramatically reduced
the hemolytic activity without affecting antibacterial activity, as compared with the homopolymer
PM6-100% lacking PEG groups. Similar to the high hemolytic activity of PM6-100%, PB-PEG-0%
without PEG content and with cationic and alkyl groups present on separate repeat units showed high
hemolytic and antibacterial activities. However, the incorporation of PEGMA-300 did not substantially
mitigate the hemolytic activity of these copolymers even at a high mol % (40%) content of PEGMA-300.
These results indicate that the PEG’s protective effect on RBCs is greatly influenced by the topographical
placements of cationic centers and hydrophobic groups along the polymer chain. A PEGylated polymer
architecture with long hydrophobic spacer arms for pendent cationic groups can result in high
antibacterial and simultaneous low toxicity towards mammalian cells.
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